Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | F2 | P00734 | 11/20 | 0.33 |
| ▸ | F10 | P00742 | 4/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 4/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 4/20 | 0.33 |
| ▸ | F12 | P00748 | 2/20 | 0.32 |
| ▸ | F7 | P08709 | 2/20 | 0.32 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.30 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6921482 | 0.86 | ALDH1A1 (0.38) | ALDH1A1IDO1F2F10PRSS1 | |
| SCHEMBL6927249 | 0.86 | F2 (0.36) | F2F10PRSS1PRSS2PRSS3 | |
| SCHEMBL6921234 | 0.84 | F2 (0.43) | ALDH1A1IDO1F2F10PRSS1 | |
| SCHEMBL6924376 | 0.84 | F2 (0.41) | ALDH1A1IDO1F2MAPK8PTGER1 | |
| SCHEMBL6929082 | 0.84 | F2 (0.40) | ALDH1A1IDO1F2F10PRSS1 | |
| SCHEMBL6923429 | 0.83 | F2 (0.41) | ALDH1A1IDO1F2F10PRSS1 | |
| SCHEMBL6923524 | 0.82 | F2 (0.38) | ALDH1A1IDO1F2F10PRSS1 | |
| SCHEMBL6927731 | 0.81 | ALDH1A1 (0.37) | ALDH1A1IDO1F2F10PRSS1 | |
| SCHEMBL6925791 | 0.81 | F2 (0.40) | ALDH1A1IDO1F2F10PRSS1 | |
| SCHEMBL6924958 | 0.80 | F2 (0.39) | ALDH1A1IDO1F2MAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6515072-B2 | Rubbery block copolymer particle dispersed phase of styrene monomers and dienic monomers; and copolymer matrix with styrenic, (meth)acrylate, and vinyl cyanide units | CHI MEI CORPORATION (TW) | 2003-02-04 | — | — | US | disclosed |
| US-20020119992-A1 | Thrombin inhibitors | MERCK & CO., INC. | 2002-08-29 | — | — | US | disclosed |
| US-20020032282-A1 | Transparent rubber-modified styrenic resin composition | CHI MEI CORPORATION (TW) | 2002-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020119992-A1 | Thrombin inhibitors | SERPINC1, F2, TFPI | ALDH1A1 4773/4885IDO1 2641/4885F2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.